Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

Current Ratio
since 2005

Microsoft Excel

Calculation

Bristol-Myers Squibb Co., current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Comparison to Competitors

Bristol-Myers Squibb Co., current ratio, long-term trends, comparison to competitors

Microsoft Excel
Bristol-Myers Squibb Co. AbbVie Inc. Amgen Inc. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2023 1.43 0.87 1.65 1.68 0.94 1.43 1.16 1.25 3.42 0.91 5.69 1.75
Dec 31, 2022 1.25 0.96 1.41 1.89 1.05 1.29 0.99 1.47 2.73 1.22 5.06 1.48
Dec 31, 2021 1.52 0.79 1.59 1.43 1.23 1.27 1.35 1.27 1.76 1.40 3.56 1.50
Dec 31, 2020 1.58 0.84 1.81 1.86 1.40 1.40 1.21 1.02 1.43 1.35 3.63 2.13
Dec 31, 2019 1.60 3.18 1.44 5.19 1.16 3.10 1.26 1.24 7.89 0.88 3.67 1.92
Dec 31, 2018 1.61 0.98 2.79 1.47 1.73 3.38 1.47 1.17 7.02 1.57 4.47 1.73
Dec 31, 2017 1.55 1.28 5.49 1.43 1.32 2.74 1.41 1.33 — 1.35 3.82 1.34
Dec 31, 2016 1.55 1.65 4.11 0.97 1.37 2.22 2.47 1.78 — 1.25 2.56 1.44
Dec 31, 2015 1.30 1.50 4.44 1.27 1.53 2.50 2.17 1.55 — 1.49 3.59 1.38
Dec 31, 2014 1.73 1.41 4.95 1.75 1.09 3.07 2.36 1.77 — 2.67 3.31 1.22
Dec 31, 2013 1.52 2.59 3.44 2.01 1.47 1.15 2.20 2.00 — 2.41 6.01 3.16
Dec 31, 2012 1.15 2.27 3.81 1.80 1.55 1.44 1.90 1.90 — 2.15 7.37 2.31
Dec 31, 2011 1.97 — 4.80 1.50 1.60 5.53 2.38 2.04 — 2.06 4.40 1.55
Dec 31, 2010 1.97 — 3.52 1.73 2.09 2.32 2.05 1.86 — 2.11 3.28 2.42
Dec 31, 2009 2.21 — 4.89 1.89 1.90 2.57 1.82 1.80 — 1.66 4.55 2.76
Dec 31, 2008 2.20 — 3.12 1.53 0.95 3.52 1.65 1.35 — 1.59 6.23 2.82
Dec 31, 2007 1.20 — 2.11 1.40 2.33 4.11 1.51 1.23 — 2.15 2.81 1.93
Dec 31, 2006 1.59 — 1.67 1.38 1.91 3.18 1.20 1.20 — 2.20 10.44 1.70
Dec 31, 2005 1.78 — 2.57 1.30 1.89 6.79 2.48 1.58 — 1.47 8.46 1.71

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Bristol-Myers Squibb Co., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Bristol-Myers Squibb Co. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2023 1.43 1.26
Dec 31, 2022 1.25 1.29
Dec 31, 2021 1.52 1.35
Dec 31, 2020 1.58 1.35
Dec 31, 2019 1.60 1.66
Dec 31, 2018 1.61 1.70
Dec 31, 2017 1.55 1.73
Dec 31, 2016 1.55 1.91
Dec 31, 2015 1.30 1.90
Dec 31, 2014 1.73 2.18
Dec 31, 2013 1.52 2.16
Dec 31, 2012 1.15 2.04
Dec 31, 2011 1.97 2.29
Dec 31, 2010 1.97 2.14
Dec 31, 2009 2.21 1.94
Dec 31, 2008 2.20 1.65
Dec 31, 2007 1.20 1.74
Dec 31, 2006 1.59 1.64
Dec 31, 2005 1.78 1.81

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Bristol-Myers Squibb Co., current ratio, long-term trends, comparison to industry (health care)

Microsoft Excel
Bristol-Myers Squibb Co. Health Care
Dec 31, 2023 1.43 1.14
Dec 31, 2022 1.25 1.16
Dec 31, 2021 1.52 1.21
Dec 31, 2020 1.58 1.21
Dec 31, 2019 1.60 1.34
Dec 31, 2018 1.61 1.38
Dec 31, 2017 1.55 1.47
Dec 31, 2016 1.55 1.68
Dec 31, 2015 1.30 1.67
Dec 31, 2014 1.73 1.87
Dec 31, 2013 1.52 1.93
Dec 31, 2012 1.15 1.81
Dec 31, 2011 1.97 1.91
Dec 31, 2010 1.97 1.80
Dec 31, 2009 2.21 1.75
Dec 31, 2008 2.20 1.42
Dec 31, 2007 1.20 1.51
Dec 31, 2006 1.59 1.39
Dec 31, 2005 1.78 1.63

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).